Medicine recalls
|
| |
| Canada: Recall: PMS-SUMATRIPTAN: may not contain the correct amount of tablets (empty blister packs) |
| |
Health Canada announces that Pharmascience Inc. is recalling one lot of PMS-SUMATRIPTAN 50mg Tablet (lot number: 74934) from retailers because the affected lot may not contain the correct amount of tablets (empty blister packs).
The product is indicated for the acute treatment of migraine attacks.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/pms-sumatriptan-may-not-contain-correct-amount-tablets-empty-blister-packs
In Hong Kong, PMS-Sumatriptan Tab 50mg (HK- 54713) is a pharmaceutical product registered by Trenton-Boma Limited. The product is a prescription-only medicine. Trenton-Boma Limited has been contacted regarding the above issue and their reply is pending.
Ends/Saturday, 30 Aug, 2025
Issued at HKT 12:00
As confirmed with Trenton-Boma Limited, the affected lot has not been imported into Hong Kong.
Content last updated: Monday, Sep 1, 2025
|
| |
